BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Syntekabio

Syntekabio logo

Founded
2009
Geography
South Korea based
Funding
$12.077 M

Syntekabio is a leading AI-driven drug discovery company that uses machine learning and supercomputing to discover new drugs.


personal genome map genome-based disease

Technologies

AI Companies (Drug Discovery)  

R&D Platform

We address the entire spectrum of drug development. We use the cutting-edge computational biology technologies for novel drug candidate discovery. We also specialize in co-developing novel drug response biomarkers of the existing drug candidates, which allows improvement of likelihood of successful clinical trial, biomarker-driven indication expansion, and enhanced understanding of the drug's mechanism of action.


NEOscan™

Read more

GBLscan™

Read more

Deep-matcher™

Read more

Pipelines

No pipelines published yet

Products

 

Services

No services posted yet